2019
DOI: 10.1002/jcp.29130
|View full text |Cite
|
Sign up to set email alerts
|

Serine peptidase inhibitor Kazal type III (SPINK3) promotes BRL‐3A cell proliferation by targeting the PI3K–AKT signaling pathway

Abstract: The serine protease inhibitor, Kazal type Ⅲ (SPINK3), is a trypsin inhibitor associated with liver disease, which highly overexpresses in a variety of cancers. In one of our previous studies of our laboratory, Spink3 was observed to be significantly upregulated in rat liver regeneration (LR) via a gene expression profile. For the current study, rat hepatocyte BRL-3A cells were treated by gene addition/ interference, and the addition of the exogenous rat recombinant protein SPINK3. It was revealed that both the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…In CRC, metastasis-specific mutations are enhanced in phosphatidylinositol 3-kinase (PI3K)/AKT signaling, cell adhesion, and ECM, implying genetic programming for specific recombination and colonization [ 39 ]. SPINK1 and SPINK3 have been suggested to promote the proliferation of colorectal cancer cells [ 16 ] and rat liver cells [ 40 ], respectively, through the PI3K/AKT signaling pathway. As mentioned previously, whether SPINK4 can downregulate HTRA1 to activate the PI3K/AKT pathway involved in rectal cancer metastasis needs further verification.…”
Section: Discussionmentioning
confidence: 99%
“…In CRC, metastasis-specific mutations are enhanced in phosphatidylinositol 3-kinase (PI3K)/AKT signaling, cell adhesion, and ECM, implying genetic programming for specific recombination and colonization [ 39 ]. SPINK1 and SPINK3 have been suggested to promote the proliferation of colorectal cancer cells [ 16 ] and rat liver cells [ 40 ], respectively, through the PI3K/AKT signaling pathway. As mentioned previously, whether SPINK4 can downregulate HTRA1 to activate the PI3K/AKT pathway involved in rectal cancer metastasis needs further verification.…”
Section: Discussionmentioning
confidence: 99%
“…We also discussed the possibility that SPINK9 can affect tumors by inhibiting KLK5. In addition, SPINK3 can also inhibit KLKs (214) and activate PI3K/ AKT by enhancing the expression of AKT1 to promote the proliferation of normal liver cells (215). Therefore, SPINK3 and SPINK9 have potential biological significance in tumors.…”
Section: Discussionmentioning
confidence: 99%
“…The aKT/erK signaling pathway is one of the most important cellular signaling pathways for cell proliferation and it has been reported to serve an important role in the occurrence and development of Hcc (40), colorectal cancer (41) and ovarian cancer (42). The aKT/erK signaling pathway has been identified to not only activate downstream signaling molecules, but also interact with other signaling molecules and result in a cascade activation (43,44). However, it is not clear whether Fer1l4 also affects the biological phenotype of cell proliferation, migration, invasion and apoptosis by mediating the aKT/erK signaling pathway in lScc.…”
Section: Discussionmentioning
confidence: 99%